Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Attenuated Versus Inactivated Flu Vaccine in Twin Sets
NCT03898986Phase 1Completed
- Sponsor
- Stanford University
- Start
- Oct 2019
- Primary completion
- Dec 2023
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised trial of live attenuated influenza vaccine and influenza virus quadrivalent inactivated vaccine in influenza (2 arms), sponsored by Stanford University. Primary endpoint: Hemagglutination Inhibition Titers at 28 days. Started Oct 2019; status: completed.
02
Drugs
live attenuated influenza vaccineinfluenza virus quadrivalent inactivated vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03898986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03898986.